Presentation of the results from AB8939 preclinical program in AML in EHA 2020 Annual Congress
10/06/2020 – AB Science will present results from AB8939 preclinical program in acute myeloid leukemia at the EHA 2020 Annual Congress
10/06/2020 – AB Science will present results from AB8939 preclinical program in acute myeloid leukemia at the EHA 2020 Annual Congress
22/05/2020 – AB Science announces the postponement of its annual general shareholders’ meeting
07/05/2020 – AB Science will host a live webcast on masitinib in combination with isoquercetin for the treatment of COVID-19 on Monday May 11, 2020
07/05/2020 – AB Science will present results from its Phase 3 study in severe asthma at the EEACI 2020 Annual Congress
06/05/2020 – AB Science granted authorization by ANSM to initiate Phase 2 study evaluating masitinib in combination with isoquercetin for the treatment of COVID-19
30/04/2020 – AB Science reports its annual financial results as of 31 December, 2019
Monthly disclosure of total outstanding shares and voting rights Dated December 4, 2017 Monthly disclosure of total outstanding shares and voting rights Dated November 7, 2017 Monthly disclosure of total outstanding shares and voting rights Dated October 2, 2017 Monthly disclosure of total outstanding shares and voting rights Dated August 7, 2017 Monthly disclosure of…
Monthly disclosure of total outstanding shares and voting rights Dated December 6, 2018 Monthly disclosure of total outstanding shares and voting rights Dated November 6, 2018 Monthly disclosure of total outstanding shares and voting rights Dated October 3, 2018 Monthly disclosure of total outstanding shares and voting rights Dated September 5, 2018 Monthly disclosure of…
Monthly disclosure of total outstanding shares and voting rights Dated December 2, 2019 Monthly disclosure of total outstanding shares and voting rights Dated November 5, 2019 Monthly disclosure of total outstanding shares and voting rights Dated October 2, 2019 Monthly disclosure of total outstanding shares and voting rights Dated September 3, 2019 Monthly disclosure of…
Monthly disclosure of total outstanding shares and voting rights Dated April 2, 2020 Monthly disclosure of total outstanding shares and voting rights Dated March 4, 2020 Monthly disclosure of total outstanding shares and voting rights Dated February 5, 2020 Monthly disclosure of total outstanding shares and voting rights Dated January 8, 2020